Stay updated on HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial page.

Latest updates to the HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.6.2 has been added, replacing the previous v3.6.0 on the page. This reflects a small metadata update to the study history display.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe history now shows that enrollment has ended, signaling not-recruiting status for the trial. It also adds a new revision note (v3.6.0) and removes the previous revision (v3.5.5) from the history.SummaryDifference0.3%

- Check26 days agoChange DetectedA new revision tag (v3.5.5) appears in the history, replacing the prior v3.5.4 and indicating an administrative update to the page.SummaryDifference0.1%

- Check48 days agoChange DetectedThe revision label on the page updated from v3.5.3 to v3.5.4, indicating a small backend or presentation update to the record history page.SummaryDifference0.1%

- Check62 days agoChange DetectedThe revision string at the bottom of the page was updated from v3.5.2 to v3.5.3, indicating a new build of ClinicalTrials.gov.SummaryDifference0.1%

- Check76 days agoChange DetectedThe history now includes a new revision entry v3.5.2 and removes the previous v3.5.0.SummaryDifference0.1%

Stay in the know with updates to HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial page.